Pre-earnings options volume in Adma Biologics (ADMA) is 9.4x normal with calls leading puts 8:3. Implied volatility suggests the market is anticipating a move near 14.3%, or $2.20, after results are released. Median move over the past eight quarters is 9.9%.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADMA: